Brief: Akoustis Reports Q1 2023 Sales Grew Over 195% Year-Over-Year

Aktis Oncology

14/11/2022 13:18

Nov 14 (Reuters) - Akoustis Technologies Inc  AKTS.O :
    * AKOUSTIS TECHNOLOGIES INC QUARTERLY REVENUE ROSE 195
PERCENT TO
$5.6 MILLION
    * AKOUSTIS REPORTS FOURTH CONSECUTIVE QUARTER OF RECORD
REVENUE AS
FIRST QUARTER FISCAL 2023 SALES GREW OVER 195% YEAR-OVER-YEAR
    * AKOUSTIS TECHNOLOGIES INC - EXPECTS TO REPORT ANOTHER
QUARTER OF
RECORD REVENUE IN CURRENT DECEMBER QUARTER WITH A YEAR-OVER-YEAR
INCREASE OF 55%-70%
    * AKOUSTIS TECHNOLOGIES INC - QTRLY LOSS PER SHARE $0.33

Source text for Eikon:  ID:nGNX7gN10Y 
Further company coverage:  AKTS.O 
 ((Reuters.Briefs@thomsonreuters.com;))